University of Michigan Rogel Cancer Center
Patients on this study will self administer Prednisone for three days before starting Radiation Therapy (RT) and continue to take 60 mg/day during the first three fractions of RT.
Inclusion Criteria: * Patients with hepatocellular carcinoma are eligible for this trial. Hepatocellular carcinoma is defined as having at least one of the following: 1. Biopsy proven hepatocellular carcinoma (HCC); or 2. A discrete hepatic tumor(s) as defined by the AASLD criteria (80) - for cirrhotic patients, \>1cm with arterial hypervascularity and venous or delayed phase washout on contrast enhanced CT or MRI. * Patients must have recovered from the acute effects of prior liver-directed therapy (e.g., RT, RFA, or TACE), and a minimum of 4 weeks must have passed since the last proced…
Patients will be treated with PO prednisone, once a day, at a dose of 60 mg/day
Arctuva estimate
Verify or correct the compensation shown for this listing.